μFBI: A microfluidic bead-based immunoassay for multiplexed detection of proteins from a μL sample volume

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Yu, Xiaobo ^a   Hartmann, Michael ^a,b   Wang, Quan ^a   Poetz, Oliver ^a   Schneiderhan Marra, Nicole ^a   Stoll, Dieter ^a,d   Kazmaier, Cornelia ^a   Joos, Thomas O ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c EDI Experimental and Diagnostic Immunology GmbH   (Germany)

^d ALBSTADT SIGMARINGEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PHYCOERYTHRIN; PROTEIN TYROSINE KINASE; REAGENT; STREPTAVIDIN;

ANTIBODY DETECTION; ARTICLE; BREAST CANCER; CANCER TISSUE; CELL LYSATE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; IMMUNOASSAY; MICROFLUIDIC BEAD BASED IMMUNOASSAY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TISSUE SECTION; TUMOR BIOPSY;

IMMUNOASSAY; LIMIT OF DETECTION; MICROFLUIDICS; PROTEINS;

EID: 78049283378     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013125     Document Type: Article

References (35)

1. Kricka LJ, Master SR, Joos TO, Fortina P (2006) Current perspectives in protein array technology. Ann Clin Biochem 43: 457-467.
2. Yu X, Schneiderhan-Marra N, Joos TO (2010) Protein Microarrays for Personalized Medicine. Clin Chem 56(3): 376-87.
3. Wulfkuhle JD, Speer R, Pierobon M, Laird J, Espina V, et al. (2008) Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res 7: 1508-1517.
4. Qiu J, Hanash S (2009) Autoantibody profiling for cancer detection. Clin Lab Med 29: 31-46.
5. Alhamdani MS, Schroder C, Hoheisel JD (2009) Oncoproteomic profiling with antibody microarrays. Genome Med 1: 68.
6. Wingren C, Borrebaeck CA (2008) Antibody microarray analysis of directly labelled complex proteomes. Curr Opin Biotechnol 19: 55-61.
7. Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, et al. (2001) Global analysis of protein activities using proteome chips. Science 293: 2101-2105.
8. Ramachandran N, Raphael JV, Hainsworth E, Demirkan G, Fuentes MG, et al. (2008) Next-generation high-density self-assembling functional protein arrays. Nat Methods 5: 535-538.
9. Jones RB, Gordus A, Krall JA, MacBeath G (2006) A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439: 168-174.
10. Schwenk JM, Lindberg J, Sundberg M, Uhlen M, Nilsson P (2007) Determination of binding specificities in highly multiplexed bead-based assays for antibody proteomics. Mol Cell Proteomics 6: 125-132.
11. Templin MF, Stoll D, Bachmann J, Joos TO (2004) Protein microarrays and multiplexed sandwich immunoassays: what beats the beads? Comb Chem High Throughput Screen 7: 223-229.
12. Yu X, Schneiderhan-Marra N, Hsu HY, Bachmann J, Joos TO (2009) Protein microarrays: effective tools for the study of inflammatory diseases. Methods Mol Biol 577: 199-214.
13. Korf U, Löbke C, Sahin Ö, Haller F, Sultman N, et al. (2009) Reverse-phase protein arrays for application-orientated cancer research. PROTEOMICS - Clinical Applications 3: 1140-1150.
14. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, et al. (2009) Tumourinitiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8: 806-823.
15. Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8: 329-340.
16. Hu L, Wang J, Baggerly K, Wang H, Fuller GN, et al. (2002) Obtaining reliable information from minute amounts of RNA using cDNA microarrays. BMC Genomics 3: 16.
17. VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, et al. (2008) Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics 7: 1902-1924.
18. Joos TO (2007) Advances in proteomics in cancer research. Expert Rev Proteomics 4: 347-349.
19. Kulasingam V, Diamandis EP (2007) Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. nature clinical practice ONCOLOGY. pp 588-599.
20. Sauer G, Schneiderhan-Marra N, Kazmaier C, Hutzel K, Koretz K, et al. (2008) Prediction of nodal involvement in breast cancer based on multiparametric protein analyses from preoperative core needle biopsies of the primary lesion. Clin Cancer Res 14: 3345-3353.
21. Hsu HY, Wittemann S, Schneider EM, Weiss M, Joos TO (2008) Suspension microarrays for the identification of the response patterns in hyperinflammatory diseases. Med Eng Phys 30: 976-983.
22. Huang RP (2007) An array of possibilities in cancer research using cytokine antibody arrays. Expert Rev Proteomics 4: 299-308.
23. Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, et al. (2009) A biomarker panel for acute graft-versus-host disease. Blood 113: 273-278.
24. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, et al. (2007) Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11: R49.
25. Knickerbocker T, Chen JR, Thadhani R, MacBeath G (2007) An integrated approach to prognosis using protein microarrays and nonparametric methods. Mol Syst Biol 3: 123.
26. Phillips TM, Wellner EF (2009) Chip-based immunoaffinity CE: application to the measurement of brain-derived neurotrophic factor in skin biopsies. Electrophoresis 30: 2307-2312.
27. Phillips TM, Wellner EF (2007) Analysis of inflammatory biomarkers from tissue biopsies by chip-based immunoaffinity CE. Electrophoresis 28: 3041-3048.
28. Phillips TM (2004) Rapid analysis of inflammatory cytokines in cerebrospinal fluid using chip-based immunoaffinity electrophoresis. Electrophoresis 25: 1652-1659.
29. Fan AC, Deb-Basu D, Orban MW, Gotlib JR, Natkunam Y, et al. (2009) Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. Nat Med 15: 566-571.
30. O'Neill RA, Bhamidipati A, Bi X, Deb-Basu D, Cahill L, et al. (2006) Isoelectric focusing technology quantifies protein signaling in 25 cells. Proc Natl Acad Sci U S A 103: 16153-16158.
31. Thor AD, Liu S, Edgerton S, Moore D, 2nd, Kasowitz KM, et al. (2000) Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer. J Clin Oncol 18: 3230-3239.
32. Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE (2009) Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptorpositive tumors. Breast Cancer Res 11: R11.
33. Baselga J, Swain SM (2009) Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 9: 463-475.
34. Bainer R, Park H, Cluzel P (2003) A high-throughput capillary assay for bacterial chemotaxis. J Microbiol Methods 55: 315-319.
35. Kim JS, Anderson GP, Erickson JS, Golden JP, Nasir M, et al. (2009) Multiplexed detection of bacteria and toxins using a microflow cytometer. Anal Chem 81: 5426-5432.